(1.03%) 5 180.74 points
(0.46%) 38 852 points
(1.19%) 16 349 points
(0.73%) $78.68
(2.61%) $2.20
(1.05%) $2 332.90
(3.73%) $27.69
(0.17%) $966.90
(-0.01%) $0.929
(-0.35%) $10.84
(-0.14%) $0.796
(-0.09%) $91.37
2.72% $ 3.02
Live Chart Being Loaded With Signals
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases...
Stats | |
---|---|
Volumen de hoy | 67 504.00 |
Volumen promedio | 122 656 |
Capitalización de mercado | 96.34M |
EPS | $0 ( 2024-03-21 ) |
Próxima fecha de ganancias | ( $-0.110 ) 2024-06-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.88 |
ATR14 | $0.0150 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Catelani Michael | Buy | 1 189 | Common Stock |
2024-04-09 | Titterton Lewis H Jr | Buy | 15 009 | Common Stock |
2024-03-15 | Baskies Arnold M | Buy | 10 000 | Common Stock |
2024-03-15 | Kumar Amit | Buy | 30 000 | Common Stock |
2024-01-12 | Baskies Arnold M | Buy | 25 000 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
61.47 |
Last 100 transactions |
Buy: 11 627 548 | Sell: 3 491 117 |
Volumen Correlación
Anixa Biosciences Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
REKR | 0.924 |
BDSX | 0.905 |
IONS | 0.899 |
SYPR | 0.894 |
LTRX | 0.892 |
UTME | 0.89 |
PEV | 0.882 |
GYRO | 0.879 |
WKME | 0.879 |
SOFO | 0.878 |
10 Correlaciones Más Negativas | |
---|---|
CFMS | -0.898 |
PAE | -0.891 |
VSEC | -0.89 |
QNST | -0.888 |
PWP | -0.885 |
COUP | -0.881 |
NATI | -0.881 |
TTD | -0.879 |
FCYIX | -0.879 |
TWNK | -0.879 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Anixa Biosciences Inc Correlación - Moneda/Commodity
Anixa Biosciences Inc Finanzas
Annual | 2023 |
Ingresos: | $210 000 |
Beneficio Bruto: | $49 000.00 (23.33 %) |
EPS: | $-0.320 |
FY | 2023 |
Ingresos: | $210 000 |
Beneficio Bruto: | $49 000.00 (23.33 %) |
EPS: | $-0.320 |
FY | 2022 |
Ingresos: | $2.47B |
Beneficio Bruto: | $2.47B (100.00 %) |
EPS: | $-0.440 |
FY | 2021 |
Ingresos: | $512 500 |
Beneficio Bruto: | $127 498 (24.88 %) |
EPS: | $-0.450 |
Financial Reports:
No articles found.
Anixa Biosciences Inc
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico